Your browser doesn't support javascript.
loading
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Morgan, Robert D; McNeish, Iain A; Cook, Adrian D; James, Elizabeth C; Lord, Rosemary; Dark, Graham; Glasspool, Rosalind M; Krell, Jonathan; Parkinson, Christine; Poole, Christopher J; Hall, Marcia; Gallardo-Rincón, Dolores; Lockley, Michelle; Essapen, Sharadah; Summers, Jeff; Anand, Anjana; Zachariah, Abel; Williams, Sarah; Jones, Rachel; Scatchard, Kate; Walther, Axel; Kim, Jae-Weon; Sundar, Sudha; Jayson, Gordon C; Ledermann, Jonathan A; Clamp, Andrew R.
Afiliación
  • Morgan RD; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK.
  • McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Cook AD; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • James EC; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Lord R; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK.
  • Dark G; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Krell J; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Parkinson C; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Poole CJ; Arden Cancer Research Centre, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK.
  • Hall M; Mount Vernon Cancer Centre, Northwood, UK.
  • Gallardo-Rincón D; Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Lockley M; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
  • Essapen S; Royal Surrey NHS Foundation Trust, Guildford, UK.
  • Summers J; Maidstone and Tunbridge Wells NHS Trust, Kent, UK.
  • Anand A; Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Zachariah A; Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK.
  • Williams S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Jones R; South West Wales Cancer Centre, Singleton Hospital, Swansea, UK.
  • Scatchard K; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Walther A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Kim JW; Seoul National University College of Medicine, Seoul, South Korea.
  • Sundar S; Pan Birmingham Gynaecological Cancer Centre and University of Birmingham, Birmingham, UK.
  • Jayson GC; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK.
  • Ledermann JA; UCL Hospitals NHS Foundation Trust and UCL Cancer Institute, London, UK.
  • Clamp AR; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. Electronic address: andrew.clamp@christie.nhs.uk.
Lancet Oncol ; 22(2): 277-288, 2021 02.
Article en En | MEDLINE | ID: mdl-33357510
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Carboplatino / Paclitaxel / Neoplasias de las Trompas Uterinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Middle aged País/Región como asunto: Europa / Oceania Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Carboplatino / Paclitaxel / Neoplasias de las Trompas Uterinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Middle aged País/Región como asunto: Europa / Oceania Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido